Thursday, May 23, 2013 Last update: 6:07 AM
Company Tech News as it Breaks
Inovio Pharmaceuticals Inc.
News articles for Inovio Pharmaceuticals Inc.:
Thursday, April 18, 2013
- Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013BLUE BELL, Pa., April 18, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it was presented Vaccine Industry Excellence (ViE) Awards for "Best Therapeutic Vaccine" and "Best Early Stage Biotech" at the World Vaccine Congress, which is being held this week in ... read more
Wednesday, April 10, 2013
- Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination DeviceBLUE BELL, Pa., April 10, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) has been selected to receive a $3.5 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) to advance the development of its next generation DNA vaccine delivery device capable ... read more
Thursday, March 28, 2013
- Inovio Pharmaceuticals to Present at BioCentury's "Future Leaders in the Biotech Industry" ConferenceBLUE BELL, Pa., March 28, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that CEO Dr. J. Joseph Kim will present an overview of the company at the 20th Annual Future Leaders in the Biotech Industry Conference taking place April 5th at the Millennium ... read more
Monday, February 4, 2013
- Inovio Pharmaceuticals to Present at BIO CEO & Investor ConferenceBLUE BELL, Pa., Feb. 4, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that CEO Dr. J. Joseph Kim will present an overview of the company at the 15th Annual BIO CEO and Investor Conference taking place February 11-12 at the Waldorf Astoria in ... read more